SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-247072
Filing Date
2021-08-16
Accepted
2021-08-16 08:58:12
Documents
59
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d163549d10q.htm   iXBRL 10-Q 816027
2 EX-31.1 d163549dex311.htm EX-31.1 11699
3 EX-31.2 d163549dex312.htm EX-31.2 11721
4 EX-32.1 d163549dex321.htm EX-32.1 5519
5 EX-32.2 d163549dex322.htm EX-32.2 5541
  Complete submission text file 0001193125-21-247072.txt   3853292

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA galt-20210630.xsd EX-101.SCH 34824
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20210630_cal.xml EX-101.CAL 24379
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20210630_def.xml EX-101.DEF 255014
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20210630_lab.xml EX-101.LAB 309772
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20210630_pre.xml EX-101.PRE 287406
11 EXTRACTED XBRL INSTANCE DOCUMENT d163549d10q_htm.xml XML 419229
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 211174820
SIC: 2834 Pharmaceutical Preparations